Global X Management Company’s Regeneron Pharmaceuticals REGN Stock Holding History

Global X Management Company’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$1.23M	Buy	3,572 +647	+22%	+$202K	0.02%	412
2018 Q1	$1.01M	Buy	2,925 +508	+21%	+$177K	0.02%	420
2017 Q4	$909K	Buy	2,417 +1,083	+81%	+$439K	0.02%	390
2017 Q3	$596K	Buy	1,334 +129	+11%	+$61.4K	0.02%	499
2017 Q2	$592K	Buy	1,205 +367	+44%	+$161K	0.02%	463
2017 Q1	$325K	Buy	838 +208	+33%	+$77.1K	0.01%	591
2016 Q4	$231K	Buy	630 +211	+50%	+$80.2K	0.01%	608
2016 Q3	$168K	Buy	419 +285	+213%	+$114K	0.01%	624
2016 Q2	$47K	Buy	134 +98	+272%	+$37.7K	﹤0.01%	723
2016 Q1	$13K	Buy	36 +32	+800%	+$13.2K	﹤0.01%	848
2015 Q4	$2K	Buy	4 +1	+33%	+$542	﹤0.01%	807
2015 Q3	$1K	Hold	3	–	–	﹤0.01%	959
2015 Q2	$2K	Buy	+3	New	+$1.46K	﹤0.01%	882

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Global X Management Company's REGN Position: Q2 2018 in Review

Global X Management Company increased its Regeneron Pharmaceuticals (REGN) stake by 22% in Q2 2018, buying an estimated $202K and bringing the position to 3,572 shares worth $1.23M. The position accounts for 0.02% of the portfolio, ranked #412.

Global X Management Company first reported a position in REGN in Q2 2015 and has held it in 13 quarters since. 624 funds tracked by Wall St. Rank hold REGN as of Q2 2018.

Global X Management Company held 3,572 shares of Regeneron Pharmaceuticals worth $1.23M as of Q2 2018.
Global X Management Company bought 647 Regeneron Pharmaceuticals shares in Q2 2018, an estimated $202K.
Regeneron Pharmaceuticals made up 0.02% of Global X Management Company's portfolio in Q2 2018, its #412 holding.
Global X Management Company first reported a position in Regeneron Pharmaceuticals in Q2 2015 and has held it in 13 quarters since.
624 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.